Phase 4 N=1,346 Smoking Cessation Intervention: Effectiveness in Primary Care
Tobacco Dependence
Primary: 6 Month Self-reported Abstinence From Smoking — 50; 52; 45; 75 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=30 Quit or Switch: E-cigarette Study
Tobacco Use
Primary: Percentage of Participants Who Report Daily Use of E-cigarettes or NRT and no Cigarette Use
N/A N=225 The Get Quit - Stay Quit Study
Nicotine Dependent Cigarette Smoker
Primary: Number of Participants Reporting no Tobacco Use in the Past 7 Days and Have a Validated CO <10ppm — 61; 55 Participants — p=.65
Phase 4 N=1,504 Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms
Nicotine Dependence
Primary: 7-day Point Prevalence of Smoking, Biochemically (Exhaled CO) Confirmed — 90; 87; 107; 84 participants with<10 ppm exhaled CO
Phase 4 N=1,251 UW Quitting Using Intensive Treatment Study (QUITS)
Tobacco Dependence
Primary: 52-Week Point-Prevalence Abstinence — 74; 79; 78; 76 Participants — p=.66
N/A N=1,647 An Innovative Conversational Agent (Quitbot) for Smoking Cessation
Smoking &Amp; Tobacco Cessation
Primary: Number of Participants With 30-day Cigarette Smoking Cessation — 191; 186 Participants — p=0.720
Phase 4 N=1,270 Smoking Cessation in Hospitalized Smokers
Smoking Cessation
Primary: Percentage of Participants With 30-day Abstinence — 18.0; 23.4; 22.1; 18.7 percentage of participants
N/A N=314 Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar
Smoking Cessation
Primary: Self-reported 7-day Point Prevalence Abstinence — 26; 31 Participants
Phase 4 N=270 Helping Those With Mental Illness Quit Smoking
Smoking · Nicotine Dependence · Mental Disorders
Primary: Acceptance of Wisconsin Tobacco Quit Line Services — 11; 6; 6 participants
N/A N=34 Youth Smoking Cessation: Therapy +/- "The Patch"
Smoking
Primary: Acceptance of Nicotine Replacement Therapy — 26 participants
Phase 2 N=746 Gradual vs. Abrupt Cessation Treatment for Smoking
Smoking Cessation
Primary: Number of Participants With Prolonged Abstinence Through 6 Months Verified by Carbon Monoxide Measurement — 12; 20; 7 participants — p=0.30
N/A N=93 Evaluation of Learning-Theory-Based Smoking Cessation Strategies
Nicotine Dependence
Primary: 4-week Abstinence — 15; 17; 29; 20 participants
Phase 4 N=517 Identifying Treatments to Motivate Smokers to Quit
Smoking · Smoking Cessation · Motivation
Primary: Percent Change in Cigarettes Smoked Per Day (CPD) — 38.7; 38.9; 37.4; 40.2 Percent Change in cigarettes per day — p=.98
N/A N=40 QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
Smoking · Smoking Cessation · Craving
Primary: Questionnaire on Smoking Urges Administered Daily Pre TMS to Measure Craving — 16; 12 units on a scale
N/A N=103 Smoking Cessation in Alcoholics
Smoking Cessation · Alcohol Consumption
Primary: Number of Smoke-free Patients — 0; 3 participants — p==.111
Phase 3 N=320 EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking
Tobacco Smoking
Primary: Number of Participants With Continuous Abstinence at End-of-Treatment (EOT) as Assessed by Self-Report and Bio-verification — 64; 57 Participants
N/A N=116 Coping Skills Treatment for Smoking Cessation
Nicotine Dependence
Primary: Number of Participants With Biochemically Verified Smoking Abstinence — 11; 12 Participants
Phase 2 N=36 Test of Novel Drug for Smoking Cessation
Smoking Cessation
Primary: Quit Status — 0.5; 0.2; 0.7; 0.5 number of days quit
Phase 3 N=216 Maintaining Nonsmoking
Nicotine Dependence
Primary: Number of Participants With Reported 7-day Point Prevalence Abstinence at Week 12 — 22; 20; 29; 20 Participants
N/A N=122 Smoking Cessation in Menthol Flavored Cigarette Smokers
Tobacco Use Disorder
Primary: Time to Lapse — 1.07; 2.55 days
N/A N=849 A Novel Treatment to Boost Quit Attempts and Cessation Among Unmotivated Smokers
Smoking · Smoking Cessation
Primary: A Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking — 208; 168 participants — p=0.008
Phase 2 N=396 Quit Smoking Study for People Who Use E-Cigarettes
Nicotine Addiction · E-Cig Use · Quitting Smoking
Primary: Biochemically Confirmed 7-day Point-prevalence Cigarette Abstinence — 16; 26; 16; 16 Participants
N/A N=2,503 Trial of An Innovative Smartphone Intervention for Smoking Cessation
Smoking
Primary: 30-day Point Prevalence Abstinence, Complete-case — 28.2; 21.1 Percentage of participants — p=<.001
N/A N=164 Smoking Cessation After Hospitalization for a Cardiopulmonary Illness
Smoking Cessation
Primary: Abstinence From Smoking — 15; 7; 13; 10 percentage of participants
Phase 4 N=490 Varenicline and Combined NRT for Smoking Cessation
Cigarette Smoker · Tobacco Use Disorder
Primary: Smoking Abstinence — 42; 63; 7; 7 Participants
N/A N=350 Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failures
Smoking, Cigarette
Primary: Proportion of Participants With Self-Reported 7-day Point Prevalence Abstinence From Cigarettes — 41; 33 Participants
Phase 4 N=112 Smoking Cessation Treatment for Methadone Maintenance Patients
Smoking Cessation · Substance-Related Disorders
Primary: Biochemically Verified Abstinence Verified With Expired Carbon Monoxide (CO) < 8 p.p.m. — 6; 0 participants — p=0.03
N/A N=633 Connect to Quit for Smoking
Smoking · Smoking Cessation
Primary: Effectiveness of CTQ vs UC — 7.5; 6.1 percentage of participants per arm
N/A N=3,120 TeleQuit Smoking Cessation Program
Smoking
Primary: 7-day Point Prevalence Abstinence From Smoking — 21; 16.4; 16.9; 16.5 percentage of participants
N/A N=2,896 Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes
Smoking Cessation
Primary: Rate of Smoking Abstinence — 33; 40; 37; 42 percentage of participants